Philippines launches pharmacy sandbox to expand medicine access

Insider Spotlight

  • Big move: Government and private sector team up on medicine access
  • Innovation: Telepharmacy and remote oversight to ease pharmacist shortage
  • Impact: Pilot could reshape Pharmacy Law and expand reach nationwide

The Philippines is taking a bold step to tackle one of its most persistent healthcare challenges: limited access to affordable, quality medicines in underserved areas. 

Through a new Regulatory Sandbox Pilot Program, the government and private sector are testing flexible pharmacy supervision models that could redefine how pharmacies operate nationwide.

Driving the News

At Malacañang Palace, President Ferdinand Marcos Jr. witnessed the signing of a memorandum of understanding between the Private Sector Advisory Council–Health (PSAC-Health), the Food and Drug Administration (FDA), and the Professional Regulation Commission (PRC). 

The deal launches the Regulatory Sandbox Pilot Program, designed to allow pharmacies to operate under telepharmacy and remote oversight mechanisms.

PSAC–Health Sector lead and Ayala Healthcare Holdings president & CEO Paolo Borromeo hands over the signed MOU to President Marcos, officially launching the Regulatory Sandbox Pilot Program with the FDA and PRC. | Photo from PCO

“By enabling pharmacies to operate with alternative supervision mechanisms, we can expand access to medicines, improve operational efficiency, and support the evolving role of pharmacy professionals in our healthcare ecosystem,” said Paolo Borromeo, Ayala Healthcare Holdings president & CEO and PSAC–Health Sector lead.

Why it matters 

The country has around 64,000 licensed pharmacists—but only 30,000 active community practitioners, far short of the 57,500 needed. Current law requires a one-to-one pharmacist-to-pharmacy ratio, limiting expansion in rural and remote areas. 

The sandbox could relax this bottleneck by enabling one pharmacist to oversee several outlets remotely while expanding the role of pharmacy assistants.

This is not just about regulatory tweaks—it’s about unlocking wider access to essential medicines, particularly for Filipinos in far-flung communities who often travel long distances just to get prescriptions filled.

President  Marcos, PSAC Lead Convenor and Aboitiz Group president & CEO Sabin Aboitiz, PSAC–Health Sector Lead and Ayala Healthcare Holdings president & CEO Paolo Borromeo, and fellow PSAC–Health members convene at Malacañang Palace for the MOU signing with the FDA and PRC, launching the Regulatory Sandbox Pilot Program to improve access to quality healthcare. | Photo from PCO

What’s Next

The pilot will run from October 2025 to October 2027, with semi-annual reviews by the FDA, PRC, and PSAC-Health to assess safety, effectiveness, and scalability. 

Results could shape amendments to the Pharmacy Law (RA 10918) and accelerate reforms under the Universal Health Care program.

If successful, the initiative could serve as a blueprint for balancing innovation with safety—making healthcare more accessible while strengthening professional standards in the process.  – Princess Daisy C. Ominga |Ed: Corrie S. Narisma

Featured News
Explore the latest news from InsiderPH
Saturday, 11 October 2025
Insight to the one percent
© 2024 InsiderPH, All Rights Reserved.